LINC00479
Putative uncharacterized protein encoded by LINC00479
Also known as: CU129_HUMAN
Protein identityUniProt · HPA
OverviewNCBI Gene
No narrative summary is available for LINC00479 in this catalog release; identity and structured annotations are shown without generated factual claims.
Canonical amino-acid sequenceUniProt
142 residues, UniProt reviewed canonical sequence.
>Q96M42|LINC00479
1 MDGGSLRASP AAMDGGALEP AQQLSSLEGW TGQDRLLIPR WREARSLSWM QSPDLESSKC
61 LTQGCCYPQA WILACSAALL QALASSDLQG SLDRVNYSRG LGPRVRLFVF PDTVGSTRKS
121 GSTGNICSVM LNVATGCVRI EKLocalizationUniProt · AlphaFold · HPA
Whether an antibody against LINC00479 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Unknown
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.48
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads LINC00479 as an antibody target. Whether an autoantibody or antibody against LINC00479 could matter depends on whether native LINC00479 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
LINC00479 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label LINC00479 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...